Boulder (Colo.) Neurosurgical & Spine Associates and the Justin Parker Neurological Institute have joined approximately 28 other sites in the U.S. to participate in the ACADIA facet replacement system investigational clinical trial.
The ACADIA is being tested as a device for treatment of lumbar spinal stenosis and has been designed to replace degenerated facet joints while restoring spinal mobility and stability.
The study is still seeking patients, both male and female, from ages 21 to 85 with lumbar spinal stenosis and at least six months of prior conservative care.
More Articles on Devices:
Smith & Nephew to Acquire Orthopedic Assets of Its Turkey-Based Distributor
US Minimally Invasive Spine Device Market to Top $3B by 2019
Baxano Surgical & US Department of Justice Reach $6M Settlement